Rentschler Biotechnologie GmbH, a contract development and manufacturing organization (CDMO) for biopharmaceuticals, has opened a new single-use bioreactor at its site in Laupheim, Germany with a capacity of 2,000 liters.   Rentschler also recently expanded its cGMP manufacturing capacity putting into operation a Twin system with two 3,000 liter stainless steel bioreactors.   Rentschler now has two 1,000 liter and two 2,000 liter single-use manufacturing systems available. This enables the c...